Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments

Published:1997-03 Issue:4 Volume:11 Page:477-483
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Staszewski Schlomo,Hill Andrew M.,Bartlett John,Eron Joseph J.,Katlama Christine,Johnson Judy,Sawyer William,McDade Hugh

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference16 articles.

1. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals

2. A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

3. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

4. Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS

5. HIV-1 RNA levels and the development of clinical disease

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new;Sexual Health;2017

2. Pharmacodynamics of Antiretroviral Agents;Methods in Pharmacology and Toxicology;2016

3. Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response;PLoS ONE;2013-04-17

4. A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation;Journal of Virology;2012-02-29

5. Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection;Expert Opinion on Pharmacotherapy;2011-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3